• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

HOFSETH BIOCARE ASA: MAJOR SHAREHOLDER NOTIFICATION

HBCRegulatory press release07.07.2026, 16.59

IFM Independent Fund Management AG, are a Liechtenstein-based fund management company acting as trustee for the following investment funds:

  • Bonafide Global Fish Fund
  • Bonafide Investment Fund – HBC II

According to the information published on the website of the Oslo Stock Exchange, the total number of outstanding shares of Hofseth Biocare ASA currently amounts to 395,081,030.
Based on this figure, IFM Independent Fund Management AG will hold a total of 12.48% of the voting rights in Hofseth Biocare ASA as of June 30, 2026.

Attachment

  • ESMA-2015-1597